Medical Devices
Medical Device MOBILE PHASE C IGF-1 AND IGF-2 IN SERUM - EUM32013
The medical device MOBILE PHASE C IGF-1 AND IGF-2 IN SERUM is realized by B.S.N. BIOLOGICAL SALES NETWORK SRL
| Trade name | MOBILE PHASE C IGF-1 AND IGF-2 IN SERUM |
| Product Code | EUM32013 |
| Manufacturer of the medical device | B.S.N. BIOLOGICAL SALES NETWORK SRL |
| Tax code of the producer | 11317290150 |
| Vat Number | 11317290150 |
| Category Name | INSULIN-LIKE GROWTH FACTOR I (SOMATOMEDIN C) |
| Category Code | W0102060403 |
| Sign repertoire | Registered |
| Group of similar Medical devices | 0 |
| Medical device reference | 0 |
| Type | Medical Device Class |
| Progressive number assigned to the medical device | 2258589 |
| Effective Date | Wednesday 25 May 2022 |
| End date | End of validity is not present for the medical device |
| End date trade | Medical device still on the market |
| Date of first publication | Wednesday 25 May 2022 |
Della stessa categoria di dispositivi medici:
- PRECIPITANT SOLUTION IGF-1 AND IGF-2 IN PLASMA SERUM - EUM32021
- IGF-1 AND IGF-2 BUFFER SOLUTION IN SERUM - EUM32022
- INTERNAL STANDARD IGF-2 IN IGF-1 SERUM PLASMA - EUM32031
- CALIBRATORS IGF-1 AND IGF-2 IN SERUM PLASMA 6 LEVELS - EUM32041
- IGF-1 AND IGF-2 CONTROL IN SERUM PLASMA 2 LEVELS - EUM32051
- - 130255007M
- - 130655007M